NRAS and neoplasm: This reduced cell proliferation in melanoma cell lines and inhibited tumour progression in xenograft melanoma NRas-mutant mouse models (determined through ex vivo Ki67 staining), which was associated with a decrease of ERK phosphorylation (Vora et al., 2020).